» Articles » PMID: 26273828

Pattern and Rate of Cognitive Decline in Cerebral Small Vessel Disease: A Prospective Study

Overview
Journal PLoS One
Date 2015 Aug 15
PMID 26273828
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Cognitive impairment, predominantly affecting processing speed and executive function, is an important consequence of cerebral small vessel disease (SVD). To date, few longitudinal studies of cognition in SVD have been conducted. We determined the pattern and rate of cognitive decline in SVD and used the results to determine sample size calculations for clinical trials of interventions reducing cognitive decline.

Methods: 121 patients with MRI confirmed lacunar stroke and leukoaraiosis were enrolled into the prospective St George's Cognition And Neuroimaging in Stroke (SCANS) study. Patients attended one baseline and three annual cognitive assessments providing 36 month follow-up data. Neuropsychological assessment comprised a battery of tests assessing working memory, long-term (episodic) memory, processing speed and executive function. We calculated annualized change in cognition for the 98 patients who completed at least two time-points.

Results: Task performance was heterogeneous, but significant cognitive decline was found for the executive function index (p<0.007). Working memory and processing speed decreased numerically, but not significantly. The executive function composite score would require the smallest samples sizes for a treatment trial with an aim of halting decline, but this would still require over 2,000 patients per arm to detect a 30% difference with power of 0.8 over a three year follow-up.

Conclusions: The pattern of cognitive decline seen in SVD over three years is consistent with the pattern of impairments at baseline. Rates of decline were slow and sample sizes would need to be large for clinical trials aimed at halting decline beyond initial diagnosis using cognitive scores as an outcome measure. This emphasizes the importance of more sensitive surrogate markers in this disease.

Citing Articles

Executive functions and processing speed in covert cerebral small vessel disease.

Jokinen H, Laakso H, Arola A, Paajanen T, Virkkala J, Sarkamo T Eur J Neurol. 2024; 32(1):e16533.

PMID: 39475227 PMC: 11622512. DOI: 10.1111/ene.16533.


Cognitive Impairment in Cerebral Small Vessel Disease Is Associated with Corpus Callosum Microstructure Changes Based on Diffusion MRI.

Dobrynina L, Kremneva E, Shamtieva K, Geints A, Filatov A, Gadzhieva Z Diagnostics (Basel). 2024; 14(16).

PMID: 39202326 PMC: 11353603. DOI: 10.3390/diagnostics14161838.


Improved Dementia Prediction in Cerebral Small Vessel Disease Using Deep Learning-Derived Diffusion Scalar Maps From T1.

Chen Y, Tozer D, Li R, Li H, Tuladhar A, De Leeuw F Stroke. 2024; 55(9):2254-2263.

PMID: 39145386 PMC: 11346716. DOI: 10.1161/STROKEAHA.124.047449.


Editorial: White matter hyperintensities: the messages beneath and beyond.

Tu M Front Aging Neurosci. 2024; 16:1367024.

PMID: 38313437 PMC: 10834768. DOI: 10.3389/fnagi.2024.1367024.


Joint diffusional kurtosis magnetic resonance imaging analysis of white matter and the thalamus to identify subcortical ischemic vascular disease.

Tu M, Huang S, Hsu Y, Yang J, Lin C, Kuo L Sci Rep. 2024; 14(1):2570.

PMID: 38297073 PMC: 10830492. DOI: 10.1038/s41598-024-52910-x.


References
1.
Nitkunan A, Barrick T, Charlton R, Clark C, Markus H . Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke. 2008; 39(7):1999-2005. DOI: 10.1161/STROKEAHA.107.507475. View

2.
Wardlaw J, Smith E, Biessels G, Cordonnier C, Fazekas F, Frayne R . Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013; 12(8):822-38. PMC: 3714437. DOI: 10.1016/S1474-4422(13)70124-8. View

3.
Rankin J . Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957; 2(5):200-15. DOI: 10.1177/003693305700200504. View

4.
Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R . MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987; 149(2):351-6. DOI: 10.2214/ajr.149.2.351. View

5.
Mok V, Wong A, Lam W, Fan Y, Tang W, Kwok T . Cognitive impairment and functional outcome after stroke associated with small vessel disease. J Neurol Neurosurg Psychiatry. 2004; 75(4):560-6. PMC: 1739014. DOI: 10.1136/jnnp.2003.015107. View